FantasticSearch

Scroll to: TopResults

Explore European Union Legislation by Asking a Legal Question

assisted-checkbox

filter-instruction-1
positive-filters
negative-filters
act-filter tabs-all

parameters-title

query

assisted-checkbox:

result-title

total 2

Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU (Text with EEA relevance. )

article  95

CELEX:  02017R0746-20250110

Electronic system on market surveillance
1. The Commission, in collaboration with the Member States, shall set up and manage an electronic system to collate and process the following information:
(a) summaries of the results of the surveillance activities referred to in Article 88(4);
(b) the final inspection report as referred to in Article 88(7);
(c) information in relation to devices presenting an unacceptable risk to health and safety as referred to in Article 90(2), (4) and (6);
(d) information in relation to non-compliance of products as referred to in Article 92(2);
(e) information in relation to the preventive health protection measures referred to in Article 93(2);
(f) summaries of the results of the reviews and assessments of the market surveillance activities of the Member States referred to in Article 88(8).
2. The information referred to in paragraph 1 of this Article shall be immediately transmitted through the electronic system to all competent authorities concerned and, where applicable, to the notified body that issued a certificate in accordance with Article 51 for the device concerned and be accessible to the Member States and to the Commission.
Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU (Text with EEA relevance. )

article  95

CELEX:  02017R0746-20250110

3. Information exchanged between Member States shall not be made public where to do so might impair market surveillance activities and co-operation between Member States.